XML 75 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
The Company's derivative financial instruments primarily consist of LIBOR-based interest rate swap contracts, which were entered into with the objective of managing exposure to variability in interest rates on the Company's debt. All interest rate swap contracts are reported in the Condensed Consolidated Balance Sheets at fair value. For the interest rate swap contracts that are not designated as hedges, changes in fair value are recognized in interest expense, net in the Condensed Consolidated Statements of Operations. For the interest rate swap contracts that are designated as cash flow hedges, changes in fair value are recognized as a component of accumulated other comprehensive income (“AOCI”) in the Condensed Consolidated Balance Sheets and are reclassified into interest expense, net in the same period in which the related interest on debt affects earnings. For interest rate swap contracts that were initially designated as cash flow hedges, however, have since been de-designated, the amounts recognized as a component of AOCI are reclassified into interest expense, net in the same period in which the related interest on variable-rate debt affects earnings through the original maturity date of the related interest rate swap contracts while changes in fair value are recognized in interest expense, net in the period in which the related interest rate swap contracts are no longer designated as cash flow hedges. The interest rate swap contracts entered into during October 2019 included a significant financing component at inception, and as
such, the related cash flows are reflected in cash flows from financing activities in the Condensed Consolidated Statements of Cash Flows.
As a result of changes in the interest rate environment in response to macroeconomic decline due to the ongoing COVID-19 Pandemic, the Company's interest rate swap contracts designated as cash flow hedges with an aggregate notional amount of $3 billion were no longer highly effective during March 2020 and as of March 31, 2020. Accordingly, the Company de-designated the cash flow hedges and the changes in fair value for the period in which these cash flow hedges were no longer highly effective were recognized in interest expense, net. Amounts recognized as a component of AOCI prior to de-designation will be reclassified into interest expense, net in the same period in which the related interest on variable-rate debt affects earnings through the maturity dates of the cash flow hedges.
Below is a summary of the Company’s interest rate swap contracts as of March 31, 2020 (in thousands):
Execution
 
Maturity
 
Designation
 
Notional Amount
January 2019
 
April 2022
 
Not designated
 
$
125,000

February 2019
 
April 2022
 
Not designated
 
300,000

October 2019
 
September 2026
 
Not designated
 
2,800,000

Total notional amount
 
 
 
 
 
$
3,225,000


The changes in fair value of interest rate swap contracts recognized in interest expense, net in the Condensed Consolidated Statements of Operations were losses of $70 million and $4 million during the three months ended March 31, 2020 and 2019, respectively. The interest rate swap contracts did not have a material impact to the Condensed Consolidated Statements of Cash Flows during the three months ended March 31, 2020 and 2019.
The fair value of the Company’s interest rate swap contracts and related classification in the Condensed Consolidated Balance Sheets for the periods presented were as follows:
(in thousands)
March 31,
2020
 
December 31,
2019
Accrued expenses and other current liabilities
$
55,804

 
$
15,334

Other liabilities
229,236

 
68,884

Fair value of interest rate swaps
$
285,040

 
$
84,218

As of March 31, 2020 and December 31, 2019, AOCI net of tax, related to cash flow hedges was $155 million and $59 million, respectively.